Alzheimer's disease in humans and other animals: A consequence of postreproductive life span and longevity rather than aging

Alzheimer's disease and diabetes mellitus are linked by epidemiology, genetics, and molecular pathogenesis. They may also be linked by the remarkable observation that insulin signaling sets the limits on longevity. In worms, flies, and mice, disrupting insulin signaling increases life span leading to speculation that caloric restriction might extend life span in man. It is our contention that man is already a long‐lived organism, specifically with a remarkably high postfertility life span, and that it is this that results in the prevalence of Alzheimer's disease and diabetes.

[1]  J. D. del Río,et al.  Reelin expression and glycosylation patterns are altered in Alzheimer's disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[2]  S Rabe-Hesketh,et al.  Head injury as a risk factor for Alzheimer’s disease: the evidence 10 years on; a partial replication , 2003, Journal of neurology, neurosurgery, and psychiatry.

[3]  D. Franks,et al.  Adaptive Prolonged Postreproductive Life Span in Killer Whales , 2012, Science.

[4]  Jin-Tai Yu,et al.  Midlife vascular risk factors and the risk of Alzheimer's disease: a systematic review and meta-analysis. , 2014, Journal of Alzheimer's disease : JAD.

[5]  E. Head,et al.  Cognitive dysfunction and the neurobiology of ageing in cats. , 2007, The Journal of small animal practice.

[6]  C. Hölscher,et al.  Intranasal Insulin as a Treatment for Alzheimer’s Disease: A Review of Basic Research and Clinical Evidence , 2013, CNS Drugs.

[7]  Z. Khachaturian,et al.  Calcium Hypothesis of Alzheimer's disease and brain aging: A framework for integrating new evidence into a comprehensive theory of pathogenesis , 2017, Alzheimer's & Dementia.

[8]  C. Kahn,et al.  Role for neuronal insulin resistance in neurodegenerative diseases , 2004 .

[9]  L. Frölich,et al.  Risk of incident Alzheimer's disease in diabetic patients: a systematic review of prospective trials. , 2009, Journal of Alzheimer's disease : JAD.

[10]  M. White,et al.  Response to Comment on "Brain IRS2 Signaling Coordinates Life Span and Nutrient Homeostasis" , 2008, Science.

[11]  M. Capucchio,et al.  Pathology of the Aging Brain in Domestic and Laboratory Animals, and Animal Models of Human Neurodegenerative Diseases , 2016, Veterinary pathology.

[12]  D. Lawler,et al.  A longitudinal study of the influence of lifetime food restriction on development of osteoarthritis in the canine elbow. , 2009, Veterinary surgery : VS.

[13]  S. Lovestone,et al.  Deletion of Irs2 reduces amyloid deposition and rescues behavioural deficits in APP transgenic mice , 2009, Biochemical and biophysical research communications.

[14]  W. Markesbery,et al.  Familial influence on plaque formation in the beagle brain. , 1992, Neuroreport.

[15]  G. Schellenberg,et al.  Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults. , 2008, Journal of Alzheimer's disease : JAD.

[16]  Sterling C. Johnson,et al.  Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease. , 2015, JAMA neurology.

[17]  E. Raff,et al.  Role of Brain Insulin Receptor in Control of Body Weight and Reproduction , 2000 .

[18]  G. Eslick,et al.  Type 2 diabetes as a risk factor for Alzheimer's disease: the confounders, interactions, and neuropathology associated with this relationship. , 2013, Epidemiologic reviews.

[19]  Teng Jiang,et al.  Meta-analysis of modifiable risk factors for Alzheimer's disease , 2015, Journal of Neurology, Neurosurgery & Psychiatry.

[20]  J. Woodgett,et al.  Targeting glycogen synthase kinase-3 (GSK-3) in the treatment of Type 2 diabetes , 2008, Expert opinion on therapeutic targets.

[21]  E. Aronica,et al.  Induction of Dickkopf-1, a Negative Modulator of the Wnt Pathway, Is Associated with Neuronal Degeneration in Alzheimer's Brain , 2004, The Journal of Neuroscience.

[22]  S. Ridgway,et al.  Dolphins as animal models for type 2 diabetes: sustained, post-prandial hyperglycemia and hyperinsulinemia. , 2011, General and comparative endocrinology.

[23]  M. Lalowski,et al.  Amyloid beta 1-42 deposits do not lead to Alzheimer's neuritic plaques in aged dogs. , 1996, The Biochemical journal.

[24]  A. Cohen Female post‐reproductive lifespan: a general mammalian trait , 2004, Biological reviews of the Cambridge Philosophical Society.

[25]  Simon Hess,et al.  Role for insulin signaling in catecholaminergic neurons in control of energy homeostasis. , 2011, Cell metabolism.

[26]  P. Cohen,et al.  Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. , 1980, European journal of biochemistry.

[27]  M. Ehrlich,et al.  Increased susceptibility to metabolic dysregulation in a mouse model of Alzheimer's disease is associated with impaired hypothalamic insulin signaling and elevated BCAA levels , 2016, Alzheimer's & Dementia.

[28]  S. Galli,et al.  Dysfunction of Wnt signaling and synaptic disassembly in neurodegenerative diseases , 2014, Journal of molecular cell biology.

[29]  G. Collingridge,et al.  The role of GSK‐3 in synaptic plasticity , 2008, British journal of pharmacology.

[30]  G. Collingridge,et al.  LTP Inhibits LTD in the Hippocampus via Regulation of GSK3β , 2007, Neuron.

[31]  T. Kirkwood Genes that shape the course of ageing , 2003, Trends in Endocrinology & Metabolism.

[32]  T. O’Brien,et al.  Pathogenesis of feline diabetes mellitus , 2002, Molecular and Cellular Endocrinology.

[33]  P. Scheltens,et al.  Risk of dementia in diabetes mellitus: a systematic review , 2006, The Lancet Neurology.

[34]  J. Busciglio,et al.  Fast axonal transport misregulation and Alzheimer’s Disease , 2002, NeuroMolecular Medicine.

[35]  Simon Lovestone,et al.  The GSK3 hypothesis of Alzheimer's disease , 2008, Journal of neurochemistry.

[36]  Chen-Yu Liao,et al.  Genetic variation in the murine lifespan response to dietary restriction: from life extension to life shortening , 2010, Aging cell.

[37]  D. Lawler,et al.  Diet restriction and ageing in the dog: major observations over two decades , 2007, British Journal of Nutrition.

[38]  Michelle K. Lupton,et al.  Complement activation as a biomarker for Alzheimer's disease. , 2012, Immunobiology.

[39]  R. Hen,et al.  Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. , 2001, The EMBO journal.

[40]  M. Verbeek,et al.  Dickkopf‐related protein 3 is a potential Aβ‐associated protein in Alzheimer's Disease , 2015, Journal of neurochemistry.

[41]  Sterling C. Johnson,et al.  Caloric Restriction Delays Disease Onset and Mortality in Rhesus Monkeys , 2009, Science.

[42]  Hubert Preissl,et al.  Brain Insulin Resistance at the Crossroads of Metabolic and Cognitive Disorders in Humans. , 2016, Physiological reviews.

[43]  L. Partridge,et al.  Dietary restriction in Drosophila , 2005, Mechanisms of Ageing and Development.

[44]  D. Franks,et al.  Reproductive Conflict and the Evolution of Menopause in Killer Whales , 2017, Current Biology.

[45]  L Partridge,et al.  Separating cause from effect: how does insulin/IGF signalling control lifespan in worms, flies and mice? , 2008, Journal of internal medicine.

[46]  Brain Insulin Signaling and Alzheimer's Disease: Current Evidence and Future Directions , 2011, Molecular Neurobiology.

[47]  Jessica M. Hoffman,et al.  The Companion Dog as a Model for the Longevity Dividend. , 2016, Cold Spring Harbor perspectives in medicine.

[48]  René Hen,et al.  Decreased nuclear β‐catenin, tau hyperphosphorylation and neurodegeneration in GSK‐3β conditional transgenic mice , 2001 .

[49]  Benjamin A. Neely,et al.  Blood-Based Indicators of Insulin Resistance and Metabolic Syndrome in Bottlenose Dolphins (Tursiops truncatus) , 2013, Front. Endocrinol..

[50]  S. Lovestone,et al.  Blood-Based Proteomic Biomarkers of Alzheimer’s Disease Pathology , 2015, Front. Neurol..

[51]  Bettina Kemme Partial Replication , 2009, Encyclopedia of Database Systems.

[52]  C. Humpel,et al.  Dkk‐3 is elevated in CSF and plasma of Alzheimer’s disease patients , 2009, Journal of neurochemistry.

[53]  K. Hawkes,et al.  Grandmothers and the evolution of human longevity: A review of findings and future directions , 2013, Evolutionary anthropology.

[54]  G. Breen,et al.  Clusterin regulates β-amyloid toxicity via Dickkopf-1-driven induction of the wnt–PCP–JNK pathway , 2012, Molecular Psychiatry.

[55]  Benjamin A. Neely,et al.  Proteomic analysis of cerebrospinal fluid in California sea lions (Zalophus californianus) with domoic acid toxicosis identifies proteins associated with neurodegeneration , 2015, Proteomics.

[56]  A. Sajantila,et al.  Post-mortem vitreous humour as potential specimen for detection of insulin analogues by LC-MS/MS. , 2013, Forensic science international.

[57]  E. Head,et al.  Ageing changes in cat brains demonstrated by β-amyloid and AT8-immunoreactive phosphorylated tau deposits , 2006, Journal of feline medicine and surgery.

[58]  H. Whitehead Life History Evolution: What Does a Menopausal Killer Whale Do? , 2015, Current Biology.

[59]  J. Woodgett,et al.  Molecular Neuroscience Review Article , 2009 .

[60]  David B. Allison,et al.  Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study , 2012, Nature.

[61]  MR spectroscopy, a new in vivo biomarker for dementia disorders? , 2015, Journal of Neurology, Neurosurgery & Psychiatry.

[62]  Emily H. Trittschuh,et al.  Long Acting Intranasal Insulin Detemir Improves Cognition for Adults with Mild Cognitive Impairment or Early-Stage Alzheimer's Disease Dementia. , 2015, Journal of Alzheimer's disease : JAD.

[63]  S. Minoshima,et al.  Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. , 2011, Archives of neurology.

[64]  S. Craft Alzheimer disease: Insulin resistance and AD—extending the translational path , 2012, Nature Reviews Neurology.

[65]  H. Eldar-Finkelman,et al.  The role of glycogen synthase kinase-3 in insulin resistance and Type 2 diabetes , 2002, Expert opinion on therapeutic targets.

[66]  B. Kalionis,et al.  The Role of Wnt Signaling in the Development of Alzheimer's Disease: A Potential Therapeutic Target? , 2014, BioMed research international.

[67]  M. Garcia-Alloza,et al.  Altered NCAM expression associated with the cholinergic system in Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.

[68]  H. Kuo,et al.  Diabetes and the Risk of Multi-System Aging Phenotypes: A Systematic Review and Meta-Analysis , 2009, PloS one.

[69]  K. Hawkes,et al.  Grandmothers and the evolution of human longevity , 2003, American journal of human biology : the official journal of the Human Biology Council.

[70]  C. Palmiere,et al.  Post-mortem determination of insulin using chemiluminescence enzyme immunoassay: preliminary results. , 2015, Drug testing and analysis.

[71]  Sterling C. Johnson,et al.  Insulin resistance predicts brain amyloid deposition in late middle-aged adults , 2015, Alzheimer's & Dementia.

[72]  G. Doblhammer,et al.  Effect of pioglitazone medication on the incidence of dementia , 2015, Annals of neurology.

[73]  Zhaohui Feng,et al.  Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats , 2002, Nature Neuroscience.

[74]  M. Fujita,et al.  Measurement of interthalamic adhesion thickness as a criteria for brain atrophy in dogs with and without cognitive dysfunction (dementia). , 2005, Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.

[75]  T. Bliss,et al.  Glycogen synthase kinase‐3 inhibition is integral to long‐term potentiation , 2007, The European journal of neuroscience.

[76]  P. Cohen,et al.  Glycogen synthase kinase-3 from rabbit skeletal muscle. , 2005, Methods in enzymology.

[77]  Claudio Franceschi,et al.  Insulin/IGF-I-signaling pathway: an evolutionarily conserved mechanism of longevity from yeast to humans. , 2003, American journal of physiology. Endocrinology and metabolism.

[78]  Daniel W. Franks,et al.  Ecological Knowledge, Leadership, and the Evolution of Menopause in Killer Whales , 2015, Current Biology.

[79]  T. Tokuda,et al.  The domestic cat as a natural animal model of Alzheimer’s disease , 2015, Acta neuropathologica communications.

[80]  J. Hardy,et al.  Has the amyloid cascade hypothesis for Alzheimer's disease been proved? , 2006, Current Alzheimer research.